Health Care

Top Trump FDA official Brenner hits pause on Novavax Covid-19 vaccine decision

Published

on

The intervention by a senior FDA official in a product decision is a highly unusual action.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version